Inflammation markers in atherosclerosis development

QR Code

Inflammation markers in atherosclerosis development

Aim. To study different inflammation markers at various stages of atherosclerosis progression.Material and methods. In 174 21-70-year-old people, brachial artery ultrasound (Aloka 5000) was performed to visualize atherosclerotic plaques and assess intima-media thickness (IMT). Immuno-enzyme analysis...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. P. Shavrin, Ya. B. Khovaeva, V. A. Chereshnev, B. V. Golovskoy
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2009-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	atherosclerosis inflammation cytokines
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1422
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Associations between intima-media thickness of carotid arteries, infectious, immune, and metabolic parameters in healthy people with no risk factors
by: A. P. Shavrin, et al.
Published: (1970-01-01)

Role of fatty acids in inflammation, atherosclerosis, metabolic disorders and gout
by: M. A. Gromova, et al.
Published: (2021-12-01)

STUDYING OF APPLICATION IMMUNOMODULATOR «GALAVIT» AT EXPERIMENTAL ATHEROSCLEROSIS
by: E. P. Turmova, et al.
Published: (2012-05-01)

NEW DIRECTIONS IN ATHEROSCLEROSIS PHARMACOTHERAPY
by: S. V. Dutova, et al.
Published: (2017-12-01)

INFLAMMATORY CYTOCINES GENES POLYMORPHISM ASSOCIATION WITH SERUM LEVELS OF BIOCHEMICAL MARKERS AT THE CORONARY ATHEROSCLEROSIS
by: A. V. Shevchenko, et al.
Published: (2014-08-01)

Atherosclerosis and inflammation – from pathogenesis to treatment: current state of affairs (Part I)
by: A. A. Avagimyan, et al.
Published: (2025-04-01)

The Junction of Allergic Inflammation and Atherosclerosis: Pathways and Clinical Implications—A Review
by: Mihaela Valcovici, et al.
Published: (2025-06-01)

Rosuvastatin effects on systemic oxidative stress, endogenous inflammation and main neoangiogenesis factors in patients with atherosclerosis
by: Yu. V. Shchukin, et al.
Published: (2009-08-01)

Atherosclerosis and inflammation – the path from pathogenesis to treatment: review of the current state of the issue (part 2)
by: A. A. Avagimyan, et al.
Published: (2025-07-01)

FEATURES OF CYTOKINE PROFILE IN PATIENTS WITH ATHEROSCLEROSIS
by: E. P. Turmova, et al.
Published: (2014-08-01)

Regulatory T Cell Immunity in Atherosclerosis
by: Hilman Zulkifli Amin, et al.
Published: (2017-05-01)

Regulatory T Cell Immunity in Atherosclerosis
by: Hilman Zulkifli Amin, et al.
Published: (2017-05-01)

Cytokines and atherosclerosis – new research directions
by: V. S. Dutova, et al.
Published: (2018-12-01)

Association of novel biomarkers of systemic inflammation with atherosclerosis and its severity
by: V. A. Shvarts, et al.
Published: (2024-10-01)

Role of blood cholesterol transport system disturbances in atherosclerosis development in rheumatoid arthritis
by: T. V. Popkova, et al.
Published: (2007-10-01)

Nanoparticles loaded with the DNA methyltransferase inhibitor SGI-1027 decrease murine atherosclerosis and inflammation in cultured human macrophages
by: Ana Cristina Márquez-Sánchez, et al.
Published: (2024-04-01)

INFLAMMATORY MEDIATORS ROLE IN ATHEROSCLEROTIC LESION DEVELOPMENT IN THE LARGE ARTERIES IN PATIENTS WITH SYSTEMIC SCLERODERMIA
by: A. L. Maslyansky, et al.
Published: (2015-06-01)

Atherosclerosis and Inflammation: Are the Rules of the Game Changing with Biological Therapies?
by: Bora R, et al.
Published: (2025-07-01)

Chlamydophila pneumoniae infection and its contribution to atherosclerosis (literature review)
by: A. L. Poznyak, et al.
Published: (2014-09-01)

Vasoprotective statin effectiveness in patients with carotid atherosclerosis
by: Yu. B. Belousov, et al.
Published: (2007-10-01)

Role of interleukin 1 in the development of atherosclerosis
by: E. L. Nasonov, et al.
Published: (2019-04-01)

ASSOCIATION BETWEEN THE DEGREE OF CORONARY ATHEROSCLEROSIS, RISK FACTORS, AND MARKERS OF CAROTID AND PERIPHERAL ARTERY ATHEROSCLEROSIS
by: N. E. Gavrilova, et al.
Published: (2013-02-01)

FEATURES OF CYTOKINE-MEDIATED REGULATION OF FOCAL AND SYSTEMIC INFLAMMATION IN COPD
by: E. A. Surkova, et al.
Published: (2014-07-01)

THE INFLUENCE OF ATORVASTATIN AND ROSUVASTATIN IN ATHEROSCLEROSIS ON THE PARAMETERS OF CELLULAR IMMUNITY AND IN VITRO LEUCOCYTE ACTIVATION
by: A. Yu. Filatova, et al.
Published: (2018-09-01)

Epicardial fat thickness and biomarkers of inflammation in patients with stable coronary artery disease: correlation with the severity of coronary atherosclerosis
by: O. A. Koshelskaya, et al.
Published: (2019-05-01)

Annexin A8 deficiency delays atherosclerosis progression
by: Carmen Gutiérrez‐Muñoz, et al.
Published: (2025-01-01)

Evaluating the Effects of Exercise on Inflammation Markers in Musculoskeletal Pain: A Systematic Review and Meta-Analysis
by: Chi Ngai Lo, et al.
Published: (2025-05-01)

Impaired tolerance of monocyte-macrophages to lipopolysaccharide in patients with coronary atherosclerosis
by: E. S. Chegodaev, et al.
Published: (2024-09-01)

DNA methylation abnormalities in atherosclerosis
by: Samira Tabaei, et al.
Published: (2019-12-01)

A prospective study on the effects of glucosamine hydrochloride and chondroitin sulfate combination on systemic inflammation markers in patients with knee osteoarthritis (report 1)
by: A. M. Lila, et al.
Published: (2025-06-01)

C-C chemokine receptor 4 deficiency exacerbates early atherosclerosis in mice
by: Toru Tanaka, et al.
Published: (2025-07-01)

Inflammation and Neurodegenerative Changes in Development of the Chronic Pathology of the Central Nervous System
by: V. M. Bondarenko
Published: (2011-12-01)

Cyanidin-3-glucoside: targeting atherosclerosis through gut microbiota and anti-inflammation
by: Zihan Tang
Published: (2025-06-01)

Disturbed shear stress promotes atherosclerosis through TRIM21‐regulated MAPK6 degradation and consequent endothelial inflammation
by: Feng Wang, et al.
Published: (2025-01-01)

System inflammation role in cardiovascular and obstetric pathology
by: M. B. Igitova, et al.
Published: (2009-02-01)

ROLE OF INFLAMMATION MARKERS IN DEVELOPMENT OF ATHEROSCLEROSIS AND ITS COMPICATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Tatiyana Valentinovna Popkova, et al.
Published: (2014-02-01)

Modern methods for studying atherosclerosis and coronary artery disease: flow cytometry
by: E. M. Stakhneva, et al.
Published: (2021-07-01)

Role of interleukin-6 in the development of atherosclerosis in rheumatoid arthritis
by: Elena Vasilyevna Udachkina, et al.
Published: (2013-10-01)

Relationship between lipid profile parameters, coagulation system and inflammation markers in patients with hypertension and multifocal atherosclerosis
by: S. S. Vedenskaya, et al.
Published: (2024-12-01)

Obesity = inflammation. Pathogenesis. How does this threaten men?
by: Z. Sh. Pavlova, et al.
Published: (2020-12-01)